NCT06287125Not yet recruiting
Renal Assessment for Early Detection of Renal Impairment in Systemic Sclerosis and Systemic Lupus Erythematosus Patients
Source: ClinicalTrials.gov · Last updated 29 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
* Evaluate renal resistive index in SSc and SLE patients for early detection of renal impairment. * Evaluate renal multi-parametric MRI in SSc and SLE patients for early detection of renal impairment. * Measure the serum levels of CD147 in SSc and SLE patients and its correlation with renal impairment. * Correlation between detected markers and other assessment tools.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 95 (estimated)
- First submitted
- 20 Feb 2024
- Start date
- 1 Mar 2024
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- Assiut University
- NCT number
- NCT06287125
What you commit to
- Study type: Observational
- Planned participants: 95
- From 1 Mar 2024 to the primary completion date, 1 Mar 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Individuals with other autoimmune diseases.
- Infections as chest infection, hepatitis C, hepatitis B and HIV infection.
- Hypertension, diabetes, heart failure, hepatic diseases, chronic renal failure, intrarenal arteriovenous fistula, obstructive nephropathy and urinary tract obstruction.
Other
- Smoking.
- Tumors as hepatocellular carcinoma.
- Contraindication for MRI as implanted metallic devices.
Who the study is looking for
- Adult (aged above 18 years) SSc patients who fulfilled the 2013 European League Against Rheumatism/American College of Rheumatology (EULAR / ACR) for SSC \[13\] and 1980 ACR criteria \[14\].
- Adult SLE Patients who fulfilled the 2019 EULAR / ACR classification criteria for systemic lupus erythematosus \[15\]
Age in the registry: 18 years to 70 years · Sex: All
This page is information, not medical advice. Discuss any trial with your doctor.